Literature DB >> 10861266

Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

B von Lampe1, B Barthel, S E Coupland, E O Riecken, S Rosewicz.   

Abstract

BACKGROUND/AIMS: Alterations in synthesis and breakdown of extracellular matrix components are known to play a crucial role in tissue remodelling during inflammation and wound healing. Degradation of collagens is highly regulated by a cascade of matrix metalloproteinases (MMPs). The current study was therefore designed to determine gene expression patterns of MMPs and their tissue inhibitors (TIMPs) in single endoscopic biopsies of patients with inflammatory bowel disease (IBD). PATIENTS/
METHODS: mRNA expression was measured by quantitative competitive polymerase chain reaction (PCR) in biopsies from patients with ulcerative colitis (n=21) and Crohn's disease (n=21). Protein expression was analysed by western blotting and immunohistochemistry.
RESULTS: MMP-2, MMP-14, and TIMP-1 mRNAs were marginally increased in inflamed, but 9-12-fold increased in ulcerated colonic mucosa in IBD whereas TIMP-2 mRNA expression remained unchanged. MMP-1 and MMP-3 mRNA expression correlated well with the histological degree of acute inflammation, resulting in more than 15-fold increased MMP-1 and MMP-3 mRNA levels in inflamed versus normal colon samples from patients with ulcerative colitis and Crohn's disease.
CONCLUSION: Profound overexpression of MMP-1 and MMP-3 mRNA transcripts suggests an important role for these enzymes in the process of tissue remodelling and destruction in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861266      PMCID: PMC1727961          DOI: 10.1136/gut.47.1.63

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  53 in total

1.  Matrix metalloproteinases in gastrointestinal cancer.

Authors:  P D Brown
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

2.  Biopsy studies in ulcerative colitis.

Authors:  S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1956-06-09

3.  Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Authors:  S Daum; U Bauer; H D Foss; D Schuppan; H Stein; E O Riecken; R Ullrich
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 5.  Matrix metalloproteinases: structures, evolution, and diversification.

Authors:  I Massova; L P Kotra; R Fridman; S Mobashery
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

6.  Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.

Authors:  N Théret; O Musso; A L'Helgoualc'h; J P Campion; B Clément
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

7.  Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases.

Authors:  S L Pender; E J Breese; U Günther; D Howie; N C Wathen; D Schuppan; T T MacDonald
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

8.  Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.

Authors:  H Wang; J A Keiser
Journal:  Circ Res       Date:  1998-10-19       Impact factor: 17.367

9.  Matrilysin expression and function in airway epithelium.

Authors:  S E Dunsmore; U K Saarialho-Kere; J D Roby; C L Wilson; L M Matrisian; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

10.  Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.

Authors:  N Hiraoka; E Allen; I J Apel; M R Gyetko; S J Weiss
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

View more
  111 in total

1.  Basement membrane components.

Authors:  A C Y Li; R P H Thompson
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

Review 2.  Fistulising Crohn's disease: MMPs gone awry.

Authors:  D Schuppan; T Freitag
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 3.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

Authors:  Ying-De Wang; Jing-Wei Mao
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

5.  Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.

Authors:  Pallavi Garg; Matam Vijay-Kumar; Lixin Wang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02       Impact factor: 4.052

6.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis).

Authors:  Emma Pirilä; Nungavarm S Ramamurthy; Timo Sorsa; Tuula Salo; Jarkko Hietanen; Päivi Maisi
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

8.  Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents.

Authors:  C Alexakis; J P Caruelle; A Sezeur; J Cosnes; J P Gendre; H Mosnier; L Beaugerie; D Gallot; M Malafosse; D Barritault; P Kern
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats.

Authors:  Jing-Wei Mao; Xiao-Mei He; Hai-Ying Tang; Ying-De Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

10.  Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.

Authors:  T Kirkegaard; A Hansen; E Bruun; J Brynskov
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.